If you cannot view the webcast, click here to download the free Flash Player.

Sponsored by Princeton CME

Target Audience

This activity is designed for clinical pharmacists.

Learning Objectives

After completing this activity, participants should be able to:

• Describe the increasing impact of antibiotic resistance on the incidence and clinical and economic burden of nosocomial infections in the United States
• Incorporate safety considerations and potential for resistance, along with coverage, into antibiotic selection for serious infections
• Implement IDSA/SHEA guidelines for antimicrobial stewardship into hospital practice
• Outline the evidence for use of traditional and new antibiotics for hospitalized patients at risk for resistance and for the prevention and management of resistant infections
• Take on a hospital leadership role to maximize infection control and prevention and management of serious infections

Credit Eligibility

To be eligible for documentation of credit, participants must participate in the full educational activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release Date: October 11, 2007

Expiration Date: October 11, 2008

Estimated time to complete: 1 hour

There is no fee associated with this activity.

Lecture Components

The audio/video presentation, post-test, and evaluation form are available as a click through via the menu at the top of this page.

CPE Accreditation

Princeton CME is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education (ACPE Provider #452) and complies with the Criteria for Quality and Interpretive Guidelines. This activity is approved for 1 hour credit (0.1 CEU) of continuing pharmacy education (ACPE #452-000-07-029-H01).

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity sponsored or cosponsored by Princeton CME may contact the Assistant Director of Continuing Education in writing. The Assistant Director of Continuing Education will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Director of Continuing Education may be made for a second level of review.

Grant Support

Supported by an educational grant from Wyeth Pharmaceuticals

Presenters

Robert P. Rapp, PharmD, FCCP
Professor of Pharmacy
University of Kentucky College of Pharmacy
Professor of Surgery
University of Kentucky College of Medicine
Associate Director for Clinical Services
Department of Pharmacy Services
University of Kentucky Medical Center
Lexington, Kentucky

Annie Wong-Beringer, PharmD
Associate Professor of Pharmacy
Vice Chair
Titus Family Department of Clinical Pharmacy and Pharmaceutical Economics Policy
University of Southern California School of Pharmacy
Los Angeles, California

Independent Clinical Reviewer

Victoria J. Dudas, PharmD
Health Sciences Associate Clinical Professor of Pharmacy
Clinical Pharmacist, Department of Pharmaceutical Services
University of California, San Francisco, School of Pharmacy
San Francisco, California

Financial Disclosure and Conflicts of Interest
According to the disclosure policy of Princeton CME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity.  All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest.  If a conflict is identified, it is the responsibility of Princeton CME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
 
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Rapp: Speaker’s honoraria—Wyeth, Ortho-McNeil. Consultant—Wyeth, Ortho-McNeil.

Dr. Wong-Beringer: Research Funding—Pfizer, Principal investigator (funds paid to University of Virginia)

Dr. Dudas: Scientific consultant—Pfizer, Astellas

Planning Committee Randy Robbin and John Savage, Princeton CME; Rosemary Hodgson, William Kormos, and Rob Brosen, Princeton Media Communications have disclosed no relevant financial relationships with any commercial interests.

Princeton CME requires all faculty to inform participants whenever off-label/unapproved uses of drugs or devices are discussed in their presentation.

The faculty has disclosed that no off-label/unapproved uses of drugs or devices will be discussed.